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Identification and Light-Dependent Translocation of a 
Cone-Specific Antigen, Cone Arrestin, Recognized by 
Monoclonal Antibody 7G6
Houbin Zhang,12 Nicolas C u en ca T a m a ra  Ivanova,4 Jill Church-Kopisb,1 
Jeanne M. Frederick,1 Peter R. Macleish,4 and Wolfgang Baehr1 2 5
P u r p o s e .  T o  elucidate the antigen recognized by monoclonal 
antibody (mAb) 7C.6, a widely used cone-specific marker. 
M e t h o d s .  7C.6 immunocytochemistry was perform ed on sec­
tions of human, primate, and bovine retina. The antigen was 
imm unoprecipitated from human retinal lysates and purified 
with protein G. Bdman degradation and liquid chromatography 
of tryptic peptides combined with tandem mass spectrometry 
(LC-MS/MS) identified the antigen.
R e s l x t s .  Sequencing of peptides derived from the immunopre­
cipitated 7G6 antigen identified it as cone arrestin. The identity 
was confirmed by Western blot analysis with recombinant 
human cone arrestin and competition with the antibody in 
immunocytochemistry. Subcellular localization of cone arrestin 
in dark-adapted and bleached bovine retinas showed that cone 
arrestin accumulated in cone outer segments of light-adapted 
retina but was more concentrated in the inner segments of 
dark-adapted retina. By expression of truncated human cone 
arrestin mutants systematically deleting areas divergent from 
bovine and primate cone arrestins, the epitope of 7G6 was 
identified as a divergent loop exposed at the surface within the 
N-domain of cone arrestin.
C o n c l u s io n s .  Several independent methods established that the 
7C.6 antigen is cone arrestin. The 7C.6 epitope is contained in 
a divergent loop, the sequence of which is conserved in bovine 
and primates but not other vertebrate species consistent with 
the specificity of the antibody. The light-dependent transloca­
tion of cone arrestin suggests a role in light- dark adaptation of 
cones. Because of the location of its gene on the X-chromo- 
some, cone arrestin is a candidate gene for X-linked cone 
dystrophies. (.Invest O ph tha lm ol Vis Sci. 2003;44:2858-2867) 
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*Tphe cone-specific monoclonal antibody (mAb) 7C.6 has 
A been shown to recognize all cone subtypes in the adult 
primate retina and the labeling for it has been observed 
throughout the cytoplasm of the cones.' The antibody 7C.6 has 
been used as a universal primate cone marker in normal and 
degenerating retina in several subsequent publications.2-3 (A 
teaching set on normal and diseased human retinas assembled 
by Ann Milam displaying retina sections stained with mAb 7C.6 
is available at h ttp://w w w .penneye.com /htm l/jeff_berger_ 
memorial.html.) The 7C.6 antigen was recently shown to colo- 
calize in the cone cytoplasm with an unidentified p45 protein 
that appears to share an epitope with the transcription factor 
NHL.' During early primate development, some heterogeneity 
in 7C.6 labeling was observed. For example, a subset of blue 
cones was delayed in their acquisition of 7C.6 immunoreactiv- 
ity, suggesting a delayed expression of the antigen, whereas 
the onset of 7C.6 immunoreactivity in red and green cones 
preceded both the expression of cone opsins and the forma­
tion of synaptic contacts in the inner plexiform layer.'
To investigate the nature of the antigen and its gene more 
closely, we first used Western blot analysis of human macula 
com ponents to determine the mobility of the antigen in S1)S- 
PAC.H. We then purified the antigen, generated proteolytic 
peptides and sequenced them by both Bdman degradation and 
liquid chromatography combined with mass spectrometry (LC- 
MS/MS). Sequence analysis of multiple fragments showed un­
ambiguously that the 7C.6 antigen is indistinguishable from 
cone arrestin (cArr, or X-arrestin). (Zhang H, Cuenca N, 
Church-Kopish J, Ivanova T, Frederick JM, MacLeish PR, Baehr 
W, ARVO abstract 1414, 2002). Arrestins are a large gene 
family involved in regulation of C.-protein-coupled receptors 
and C.-protein-linked cascades. The cone’s visual cascade is 
thought to function very similarly to that of rods, but is com­
posed of com ponents encoded by distinct genes. Most of these 
com ponents have been cloned and characterized, including 
cone pigments,5 cone transducin a-subunit,6 cGMP Pl)Ba ',7 
and cyclic nucleotide gated channel a(CNG3)8 and j3 subunit.9 
Most regulatory components such as guanylate cyclase-activat­
ing protein (CC.AP)-I, 10 guanylate cyclase (GO-1 , 11 RC.S9-1, 12 
C.-protein-coupled receptor kinase (C.RK)-I, 13 and recov- 
erin'~K' 5 are p resent jn both rocjs ancj cones in mammals. 
Exceptions are the arrestins, which occur in cell-specific iso­
forms.
One hallmark of arrestin function is its relocalization in the 
rod cell in a light-dependent manner. In dark-adapted retina, 
arrestin is located in the inner segment, but redistributes rap­
idly to the outer segment on illumination. '617 Recently, cone 
arrestin was shown to translocate in the mouse retina, depend­
ing on illumination. '8 We found that bovine cone arrestin 
redistributes similarly in light- and dark-adapted bovine retina. 
In the light, cone arrestin accumulates in the cone outer seg­
ments, presumably interacting with bleached cone visual pig­
ments and quenching the cone cascade. In contrast, in the 
dark, cone arrestin accumulates in the inner segment. The 
light-dependent translocation of cone arrestin depending on
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light history, similar to  that of rod arrestin, suggests a novel 
mechanism of light- dark adaptation in cones.
M a  iekiai s ajnd M e th o d s
Immunoprecipitation and Peptide Sequencing
Retinal extracts w ere prepared from human macular buttons obtained 
from the Lions Eye Bank at the University of Utah 4 to  8 hours after 
death. A crude extract, of human maculae was mixed with 7G6 anti­
body and protein-G- coupled agarose (Santa Cruz Biotechnology, Santa 
Cruz, CA) in TP buffer (20 mM Tris [pH 7.5], 150 mM NaCl, and 0.1% 
Tween 20). The mixture was incubated 2 hours at room tem perature 
on a rocking platform. The agarose beads w ere pelleted by brief 
centrifugation and washed three times with TP buffer. SDS (2X gel 
loading buffer (45 fxT.) was added to the agarose beads followed by­
boiling for 2 minutes to  elute the bound proteins completely. The 
proteins w ere fractionated by 10% SDS-PAGE gel and stained with 
Coomassie blue dye. Stained bands corresponding to the antigen were 
excised from SDS-PAGE gel and submerged into destaining solution 
(0.2 M NH4HCOs containing 30% acetonitrile). After incubation at 
30°C for 1 hour, the liquid was removed, and the fresh destaining 
solution was added. The process was repeated until the gels were 
completely destained. The gels w ere then fully dehydrated in a con­
centrator (SpeedVac; Thermo Savant, Holbrook, NT). For in-gel diges­
tion, the dried gels w ere rehydrated with 40 fxT. 0.2 M NH4HCOs 
containing 0.4 /xg sequencing-grade trypsin (Promega Corp., Madison, 
WT). The proteolysis was stopped by adding 1/10 volume of 10% 
trifluoroacetic acid (TFA). The released peptides w ere extracted sev­
eral times from the gel with 100 /xT. o f 0.1% TFA and 60% acetonitrile 
followed by concentration (Speed-Vac; Thermo Savant) concentration. 
The mixed peptides w ere submitted to the  peptide-sequencing core 
facility in University o f Utah for separation by HPLC and sequencing by 
Edman degradation. Meanwhile, the peptide mixture prepared under 
the same conditions was submitted to  the mass spectrom eter core 
facility (University o f Utah) and analyzed by T.C/MS-MS. The tryptic 
peptides w ere loaded onto an HPLC system linked to a mass spectrom ­
eter (T.CQ Deca; Thermo Finnigan, San Jose, CA). The peptides were 
eluted into the mass spectrom eter and MS/MS spectra w ere generated. 
The spectra w ere subjected to search against the databases on com­
puter with a commercially available program (Sequest. Software, Lisle, 
TT.) to find the  matched peptides. The retrieved peptide sequences 
w ere com pared with the sequences in GenBank (http ://w w w .ncbi. 
nlm.nih.gov/Genbank; provided in the public domain by the National 
Center for Biotechnology Information, Bethesda, MD).
Western Blot Analysis
Human maculae w ere isolated from freshly obtained retinas using a 
trephine (6 mm diameter). Two maculae w ere dropped into a micro­
centrifuge tube and hom ogenized with a plastic pestle in 100 /xT. 
hypotonic buffer A (20 mM Tris, [pH 8.0], 1 mM EDTA, 1 mM dithio­
threitol [DTT], and 100 /xM phenylmethylsulfonyl fluoride [PMSF]). 
The tissue lysate was centrifuged at 600^ for 5 minutes at 4°C. The 
supernatant was removed and saved, and the pellet was homogenized 
again in buffer A and recentrifuged as before. The supernatants from 
these two centrifugations w ere combined and subjected to ultracen­
trifugation at 250,000^ for 1 hour at 4°C. One tenth of the supernatant 
and the  entire pellet from ultracentrifugation w ere subjected to 10% 
SDS-PAGE gel electrophoresis, and the  resolved polypeptides were 
transferred to a nitrocellulose filter (Bio-Rad, Hercules, CA). The filter 
was probed with mAb 7G6 (1:150) followed by horseradish peroxidase 
[HRP]-conjugat.ed secondary antibody. The signal was visualized using 
phosphorescence (F.CT. system; NF.N T.ife Science, Boston, MA) and 
detected by x-ray film.
Immunocytochemisty and Preabsorption Assay
Monkey eyes w ere obtained from the Texas Primate Center (Alice, TX) 
and fixed as described previously.19 Adult human and bovine eyes
w ere dissected to remove the anterior segment, and the  eye cup was 
transferred to freshly prepared 4% paraformaldehyde in 0.1 M phos­
phate buffer (pH 7.4). After fixation for 2 hours at room temperature, 
the eye cup was immersed in 10% sucrose in 0.1 M phosphate (1 hour), 
20% sucrose in 0.1 M phosphate (1 hour), and 30% sucrose in 0.1 M 
phosphate buffer (overnight). A small piece of retina-RPF, was isolated 
with a razor blade, em bedded in commercial medium (TBS; Triangle 
Biomedical Sciences, Durham, NC) and frozen. Sections (12-/xm thick) 
w ere cut with a cryostat and m ounted on gelatin-coated or charged 
slides (Superfrost/Plus, Fisher Scientific, Pittsburgh, PA). Bovine sec­
tions from light- and dark-adapted specimens w ere m ounted pair-wise 
so that tissues from both w ere incubated in the same pool of antibody 
solution. This facilitated direct comparison of 7G6 immunolocalization 
correlating with light versus dark adaptation.
For immunocytochemistry, the  sections w ere blocked with 0.1 M 
phosphate buffer (pH 7.4), containing 1% BSA, 0.1% Triton X-100, and 
10% normal goat serum, and probed by 7G6 antibody (1 :100 or 1:200 
dilution) followed by FTTC-conjugated goat anti-mouse or TRTTC-con- 
jugated goat anti-mouse secondary antibody. For double labeling, the 
sections w ere incubated simultaneously with mAb 7G6 and polyclonal 
antibodies anti-calbindin (Swant, Bellinzona, Switzerland) overnight at 
4°C. Sections w ere visualized by application of rhodamine (TRTTQ- 
conjugated goat anti-mouse and FTTC-conjugated goat anti-rabbit, sec­
ondary antibodies. The immunolocalization was imaged using a con- 
focal microscope (model T.SM 510; Carl Zeiss Meditech, Thornwood, 
NT) set. to an optical slit, of 1 /xm.
A preabsorption study was perform ed to verify 7G6 antibody spec­
ificity. Fresh human retina was obtained from a 4-month-old infant, 
whose eye was enucleated because of retinoblastoma (biopsy tissue 
provided by Nick Mamalis, University of Utah). The nontumorous 
portion of the retina-RPF. was dissected 2.5 hours after enucleation, 
fixed for 2 hours in 4% paraformaldehyde in 0.1 M phosphate buffer 
(pH 7.4), and cryoprotected in sucrose. Frozen sections w ere blocked 
for 1 hour with 10% normal goat, serum before incubation with mAb 
7G6. As a negative control, 7G6 (1 :200) was preabsorbed for 6 hours 
with an excess amount, of recombinant, human cone arrestin ( — 15 /xg 
rCArrHis/50 /uT. solution) before the solution was applied to the  sec­
tions of retina. Tmmunoreactive sites w ere visualized by incubation 1 
hour in FTTC-conjugated goat, anti-mouse TgG (1:300, cat.. #115-095­
146; Jackson TmmunoResearch, West. Grove, PA) as the secondary 
antibody and imaged as described for immunocytochemistry.
Expression and Purification of Human 
His-Tagged Cone Arrestin
The human His-tagged cone arrestin (hcArrHis) expression construct, 
was kindly provided by Cheryl Craft. (University of Southern Califor­
nia). For this construct, full-length human cone arrestin cDNA was 
cloned in frame into an expression vector (pTRC-His B; Promega). The 
plasmid was transformed into lischevichia coli F.R2556 (New England 
Biolabs, Boston, MA), and a single colony was inoculated into 5 mT. 
Luria-Bertani (T.B) medium and grown at. 37°C. The overnight, culture 
was diluted into 100 mT. o f and continued growing to an OD600 of 0.6t.o 
0.7. Tsopropyl-jS-D-l-thiogalactopyranoside (TPTG) was added to the 
culture to a final concentration of 1 mM to induce the expression of 
recombinant, protein. After 5 hours of induction at. 37°C, the culture 
was harvested. The cells equal to 1.5 mT. o f culture w ere lysed with 
lysozyme, and a fraction of the lysate was analyzed by W estern blot, 
with 7G6 antibody. Recombinant. hcArrHis was purified from 500 mT. 
of culture with a HisTrap column (Pharmacia/Amersham, Piscataway, 
NJ) according to  the manufacturer’s instructions. The purified protein 
was verified by SDS-PAGE gel and quantified using a protein assay kit. 
(Cat., no. 500-0006; Bio-Rad).
Mutagenesis
To prepare human cone arrestin deletion mutants, mutagenesis was 
perform ed with a kit. (QuickChange; Stratagene, T/aJolla, CA). Five 
deletion mutants (see Fig. 4A) introducing stop codons after codons
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97, 168, 187, 343, and 355 w ere generated. Briefly, two complemen­
tary primers harboring a nonsense mutation in the center correspond­
ing to the desired stop position were synthesized (DNA synthesizer 
model 392; Applied Biosystems, Foster City, CA). Simultaneously, a 
silent restriction site iX ba \) was introduced into the primers to test the 
newly generated plasmid DNAs for successful mutagenesis by X ba\ 
restriction digest. The primers w ere mixed with 50 ng of template 
plasmid and recom binant f f ti  polymerase, and the amplification was 
performed for 16 cycles according to manufacturer's instructions. 
Methylated template DNA was removed by digestion with Dpn\. A 
small aliquot of the reaction mixture was used to transform E. coli. 
The mutation was confirmed by DNA sequencing (Prism capillary 
sequencer; Applied Biosystems). The TPTG-induced expression, purifi­
cation of the truncated proteins and W estern blot w ere performed, as 
described earlier.
D eterm ination o f  Arrestin Gene Structures
Contigs from human (AT.357752), mouse (AC091784), rat (AC095218), 
and zebrafish (AT.590151) w ere identified by screening the National 
Center for Biotechnology Information (NCBI) high-throughput gene 
sequences (htgs) using cone arrestin protein sequences and tblastn 
(NCBT database). Gene structures w ere determined with cDNA or 
protein sequences as templates. The novel zebrafish cArr gene struc­
ture was derived using 15 zebrafish cArr expressed sequence tags 
(ESTs)—AW826248, AW826514, BE015717, BE015912, BE016049, 
BF937662, BF937816, BF938932, BG305632, BG306321, BG306785, 
BG306798, BT706094, BT879022, and BT879162— covering the entire 
mRNA from the transcription start point to the poly(A) tail. Splice 
variations w ere exam ined in all genes using partial cArr-specific ESTs. 
Software tor DNA analysis was Oniiga 2.0 (Accelrys, Cambridge, UK; 
available at http://www.accelrys.com /dstudio/ds_gene/) and DNA * 
(DNAstar, Inc., Madison, WT; http://w ww.dnastar.com ), both available 
commercially.
Light and Dark Adaptation o f  Bovine Eyes
A pair of freshly enucleated bovine eyes was obtained from a local 
abattoir. One eye was dark adapted tor 3 hours on ice in a light-tight 
metal can sealed with black tape and dissected in a darkroom under 
dim red light. The retina-RPE was fixed in the dark with 4% parafor­
maldehyde solution. The other eye, placed on ice, was kept at room 
light with an intensity of approximately 500 lux (normal room light). 
The eye was dissected in normal room light, and the retina-RPE was 
fixed in 4% paraformaldehyde and processed for immunocytochemis­
try, as described earlier.
R esults
Specificity o f  mAb 7G6
We first explored the cell specificity of the mAb 7G6 in human, 
bovine, and primate retina (Fig. 1). Staining human frozen 
sections w ith 7G6 (Fig. IB) reveals expression of the antigen 
exclusively in cones, apparently distributed throughout the 
cell including cone pedicles, somata, and inner and outer 
segments. Human retina incubated w ith a polyclonal anti-cal- 
bindin antibody (Fig. 1A) reveals labeling in the cytoplasm of 
the long-wavelength (LW) cone inner segments, the cell bod­
ies, and the synaptic pedicles. Staining in the outer segments 
w ith this antibody is relatively weak. Note that short-wave- 
length (SW) cones are only very faintly labeled with anti- 
calbindin. The identity of these cones as SW cones was re­
cently confirmed by double labeling w ith anti-blue opsin 
antibody.20 Anti-calbindin also labeled bipolar cells which are 
7G6 immunonegative (results not shown). The function of 
calbindin, an FF hand containing small Ca2+ binding protein 
w ith widespread distribution in neurons, is unknown, but it 
has been suggested that it transports intracellular Ca2+ and
protects against Ca2+ mediated apoptosis.21 When human ret­
ina sections w ere double labeled with anti-calbindin and 7G6 
(Fig. 1C), synaptic pedicles and inner segments of LW cones, 
but not SW cones, showed colocalization. Apart from human 
(Figs. 1B, 1C) and monkey (Fig. 1F) retinas, only bovine cones 
w ere found to be immunopositive w ith mAb 7G6 (Fig. ID). 
Labeling of other vertebrate retinas (mouse, ground squirrel, 
salamander) w ith 7G6 was unsuccessful (results not shown), 
indicating that the 7G6 epitope is only present in primate and 
bovine antigens. The results are consistent with mAb 7G6 
recognizing an antigen present nearly exclusively in the cyto­
plasm of primate and bovine cone photoreceptors. Uniform 
labeling with 7G6 and variation in double labeling w ith anti- 
calbindin suggests that the 7G6 antigen is present in all cone 
subtypes.
Identification o f  the 7G6 Antigen
To identify the 7G6 antigen in cones, w e used Western blots 
w ith macular extracts from human retina (the macula is rich in 
cone photoreceptors). Western analysis revealed the presence 
of the 7G6 antigen exclusively in the hypotonic supernatant, 
and its absence in the membrane pellet (Fig. 2A). The apparent 
mobility in denaturing SDS gels is approximately 44 to 46 kl)a, 
independent of denaturing the extract at high or low tem per­
atures. To immunoprecipitate the 7G6 antigen, the hypotonic 
macular extract was incubated w ith mAb 7G6 and protein-G- 
coupled agarose.22 The immunoprecipitate was analyzed by 
SDS-PAGF (Fig. 215) revealing lgC, (Fig. 215, arrow 1) and the 
7G6 antigen (Fig. 2B, arrow 2). We then determined proteo­
lytic peptide sequences of the imm unoprecipitated 7G6 anti­
gen by two independent methods: Fdman degradation and 
LC-MS/MS. Fdman degradation of a single proteolytic polypep­
tide yielded a sequence identical w ith a short fragment of 
human cone arrestin (cArr) at positions 166-175 (Fig. 2C). 
Separation of a mixture of proteolytic fragments by liquid 
chromatography and subsequent mass spectrometric analysis 
of individual peaks allowed identification of fragments cover­
ing essentially the entire cArr polypeptide, except for the 
N-terminal region (Fig. 2C). The results show com plete identity7 
of the 7G6 antigen w ith human cArr, a polypeptide of 388 
amino acid residues. The calculated molecular mass of human 
cArr is 43 kl)a, consistent w ith the apparent mobility of the 
7G6 antigen (4 4 -4 8  kl)a, Fig. 2A). In control experiments, we 
expressed His-tagged human cArr in bacteria and analyzed the 
recombinant protein by Western blot analysis (Fig. 2D). The 
results show that the recombinant protein has an apparent 
mobility of 50 kl)a, slightly larger than the 7G6 antigen (the 
recombinant protein carries a His tag), and is immunopositive 
w ith mAb 7G6. When the mAb 7G6 is preabsorbed with 
recombinant cArr, immunohistochemical labeling of cones 
w ith 7G6 is completely abolished (Fig. 2F). These results es­
tablished unambiguously that the 7G6 antigen is cone arrestin.
Light-Dependent Redistribution o f  Cone Arrestin
The identification of the 7G6 antigen as cone arrestin raised the 
interesting question of w hether cone arrestins redistribute in 
cones, as has been observed for rod arrestin (S-antigen) and 
other phototransduction com ponents (for review, see Ref. 23). 
In dark-adapted mammalian retina, arrestin is located in the 
inner segment, but moves rapidly to the outer segment, on 
illumination. This apparent movement was controversial for 
many years, but recently was shown to occur unambiguously 
w ith rod T a .2 J Because dark-adapted primate retinas are very 
difficult to obtain, w e performed a series of experiments with 
light- and dark-adapted bovine retinas, the only mammalian 
species besides primates w ith 7G6 immunoreactivity (Fig. ID). 
In dark-adapted bovine retinas, cone arrestin distributes
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F ig u r e  t .  Specificity o f mAb 7C'.6in 
human, bovine, and monkey retina.
(A) Labeling of human cone photore­
ceptors with a commercially avail­
able polyclonal anti-calbindin anti­
body. Calbindin immunolocalization 
is indicated by green labeling (FITC- 
conjugated secondary antibody). The 
brightly labeled cones are I,W cones, 
and the faintly labeled cones are SW 
cones.211 Calbindin was present in 
cone pedicles and the  cytoplasm of 
cone inner segments and at lower 
levels in the outer segments. (B) La­
beling of human cone photorecep­
tors with 7G6 antibody visualized 
with rhodamine-conjugated second­
ary antibody. Note uniform labeling 
of LW and SW cones. (C) Double 
labeling with anti-calbindin and 7G6 
antibodies. Colocalization of calbin­
din and 7G6 antigen was strongest in 
the inner segments and synaptic 
pedicles o f LW cones. (I>) Bovine 
sections of retina w ere labeled with 
7G6 (red). As in humans, all o f the 
cone cells including synaptic 
pedicles labeled with 7G6. (E) Ma­
caque retinas w ere labeled with 
FlTC-conjugated secondary antibody. 
AH retinas w ere fixed under normal 
room light, and no precautions for 
dark adaptation or complete bleach­
ing w ere taken.
throughout the cytoplasm of cones, but accumulates predom ­
inantly in the myoid region of cone inner segments (Fig. 3A), 
the region where biosynthesis takes place. In the light, cone 
arrestin accumulates strongly in the outer segments (Fig. 3B), 
presumably interacting with bleached cone visual pigments 
and inactivating the cone cC.MP cascade. Accumulation of 
these com ponents in distinct compartments of photoreceptors 
suggests the presence of a novel mechanism of photoreceptor 
light- and dark-adaptation in both rod and cone photorecep­
tors.
Cone Arrestin Genes
To investigate potential links to human retina disease and the 
diversity7 of cone arrestins, we next analyzed vertebrate cone 
arrestin gene structures. The human and mouse cone arrestin 
genes have been cloned, and their exon-intron arrangement 
has been determined .25-26 These genes were shown to consist 
of 17 exons (one noncoding exon is located in the 5'untrans- 
lated region [UTRJ). We identified human (AC068231, 
AL357752) and mouse (AC091784) genomic contigs in C.en- 
Bank that verified the published gene structures (Figs. 4A, 4B).
The human contig AL357752 containing the entire cArr gene 
localized the gene to chromosome X (c|13-2-21.1) which sig­
nificantly narrowed the published locus (Xcen-Cq22).25 In ad­
dition to human and mouse, we determined the gene struc­
tures of rat (R attus norveglcus) and zebrafish (D a n io  rerlo ) 
cArr from large anonymous contigs (AC095218, AL590151) 
containing the entire cArr genes. As expected, the rat cArr 
gene structure (Fig. 4C), consisting of 17 exons, was nearly 
identical with that of mouse and human (Figs. 4A, 4B). In 
contrast, the zebrafish cArr gene (Fig. 4C) consisted of only 16 
exons and encoded a 362 amino acid polypeptide with a 
significantly truncated C-terminal region. The zebrafish cArr 
gene features an exon 15 that is only 4 bp (one amino acid) in 
length, separated from exons 14 and 16 by a 302 and 91 bp 
introns, respectively. Like the mammalian cArr genes, the first 
exon is located in the 5'UTR. The predicted RNA and amino 
acid sequences were verified by 15 independent KSTs (10 of 
which are shown in Fig. 41)) that cover the entire 5'LJTR, the 
coding sequence, and the 3'LJTR. In contrast to com plex alter­
native splicing observed in human and mouse cArr genes,25-26 
the zebrafish KSTs deposited in C.enBank show no significant
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F ig u r e  2 .  Identification of the 7G6 
antigen. (A) SDS-PAGE (10% poly­
acrylamide gel) followed by W estern 
blot o f hypotonic human macula ex­
tract probed with mAb 7G6. The 
membrane fraction was separated 
from soluble proteins by ultracentrif­
ugation. The antigen was detected by 
Western blot with 7G6 antibody. HR. 
homogenate supernatant boiled; HU. 
homogenate supernatant unboiled. 
HP. homogenate pellet. (B) Tmmuno- 
precipitation of antigen with mAb 
7G6. The human macular crude ex­
tract obtained after ultracentrifuga­
tion was incubated with mAb 7G6 
and protein G-coupled agarose. The 
immunoprecipitate was analyzed by 
SDS-PAGE. Arrow  I : TgG; a tro w  2 : 
7G6 antigen. (Q  Sequence determi­
nation of proteolytic peptides. The 
peptide sequences unambiguously 
match human cone arrestin. Peptide 
sequences identified by Edman deg­
radation are underscored in blue. 
and sequences identified by I.C- 
MS/MS are underscored in red. (D) 
Western blot of bacterial recombi­
nant His-tagged human cone arrestin. 
The bacterial pellet was lysed by son­
ication. and the soluble fraction was 
probed with mAb 7G6. The immu- 
nopositive antigen has a mobility of 
--50 kDa {arrow). (E) Competition 
of mAb 7G6 with recombinant hu­
man cone arrestin. T.eft: human 
4-mont.h-old retinoblastoma retina 
was probed with mAb 7G6 (1:100 
dilution) overnight at 4°C. Right. 
mAb 7G6 preabsorbed 6 hours with 
15 jug recom binant cone arrestin and 
incubated overnight as in (A). Re­
combinant cone arrestin abolished 
the native cone arrestin.
variation in splicing (apart from one KST with a short deletion 
in the 3'UTR). Phylogenetic analysis of the polypeptide se­
quences reveals that rod and cone arrestins fall into two dis­
tinct, but closely related subfamilies, as has been shown pre­
viously. ' 7 The 7C.6 epitope, however, is only present in 
primate and bovine cone arrestins.
Functional and D ivergent D om ains in  
Cone Arrestins
Vertebrate rod and cone arrestin amino acid sequences are 
highly conserved (Fig. 5) suggesting that the overall three­
dimensional structure cone arrestin is very similar to  that of rod 
arrestin. The 0.28-nm crystal structure of rod arrestin showed 
a bipartite molecule consisting of N- and C-domains.~s The 
sequence similarity among rod arrestins is 51% to 83% (com­
pared with bovine arrestin), among cone arrestins 52% to 84% 
(compared to bovine cone arrestins). Bovine arrestin is 47% to 
55% similar to  all cone arrestins shown in Figure 5. The arrestin 
signature region (positions 57-75 in human cArr) is essentially 
unaltered among all arrestins. Two N-linked glycosylation sites
(Fig. 5, gray boxes) are conserved in the rod and cone arrestins, 
but N-glycosylation has not been established in arrestins (one 
report' 9 suggested that a small population of rod arrestin may 
be glycosylated). Among vertebrate cone arrestins, several re­
gions are divergent, the C-terminal region (last 30 residues) and 
three relatively short regions of approximately 10 to  20 resi­
dues in the N-terminal half and the central part of the molecule 
(Fig. 5, bars 1-4). Region 3 in cone arrestin is analogous to a 
linker connecting tw o 0 sheets in the N- and C-domains of 
arrestin, respectively. In rod arrestin, the C-terminal region is 
important for locking arrestin into an inactive state.~s Se­
quence divergence in this region suggests flexibility in the 
length to  exert this important function.
The amino acid sequences in Figure 5 are from the follow­
ing sources: hum_cArr, accession no. 13633229 (National 
Institutes of Health); bov_cArr, accession no. D8534036; 
mus_cArr, accession no. NP_573468; rat cArr, derived from 
contig AC095218; xen_cArr, accession P51483'7; /cbArr3 
(D an io  rerio), derived from a cDNA sequence extracted from 
an anonymous genomic contig, accession no. AL590151 (Sanger
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F ig u r e  3. Redistribution of cone ar­
restin in bovine cones, depending on 
the light history. (A) Dark-adapted 
bovine retinas. mAb 7G6 labeled the 
synaptic pedicles, the somata. and 
the inner and outer segments o f the 
cones. In the dark, the  bulk of cone 
arrestin was concentrated in the my- 
oid region, the  place of biosynthesis.
(B) Fully bleached bovine retina. The 
bulk of cone arrestin was in the outer 
segments, where phototransduetion 
occurs. The confocal images shown 
are representative of experiments 
performed with three different pairs 
of eyes in the fall of 2001 and the 
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F igure  4 . Gene structu res of vertebrate cone arrestins. The exon-intron arrangements were determined from publicly available anonymous 
contigs deposited in GenBank: hum an cArr contig. AL357752. containing a complete hum an cArr DNA sequence on chromosome X (ql3.2-21.1; 
length. 178.868 bp); mouse cArr contig AC091784. length 215.734 bp; rat cArr contig. AC095218. 73 unordered pieces (length. 183.219 bp); and 
zebrafish cArr contig AL590151. in ordered pieces, length 136.930 bp. Several independent zebrafish ESTs. show n below the gene diagram, are 
consistent with the predicted RNA/amino acid sequences of zebrafish cArr. Three ESTs extend presumably to the transcription start point al the 
beginning of the 5'UTR exon. Two 3'UTR ESTs carry poly(A) tails. A composite zebrafish cArr mRNA sequence from the transcription start point 
to the beginning of the poly(A) tail has been deposited in GenBank. Black boxes: coding exons; gray boxes: noncoding exons.
Centre, H inxton Hall, UK); bov_Arr, bovine arrestin (accession 
AAA30377); mus_Arr, mouse arrestin (accession no. NP_03314); 
and hum_arr, hum an arrestin (accession no. 14737493). The 
sequences w ere aligned w ith Clustal W  (http://w w w .ebi.ac.uk/ 
clustalw/ provided in the public domain by the European Bioin­
formatics Institute, European Molecular Biology Laboratory , Hei­
delberg, Germany) and shaded w ith Boxshade (h ttp ://w w w . 
ch.em bnet.org/softw are/box_fom i.htm l/ provided in the public 
domain by the Ludwig Institute of Cancer Research and the ISREC 
Bioinformatics Group, Swiss Institute o f Bioinfomiatics, Basel, 
Switzerland).
Identification o f  the mAb 7G6 Epitope
To determ ine th e  ep itope  for 7G6 in hum an cone arrestin, w e 
systematically deleted  th e  divergent regions, starting at the 
C-terminal end, and assayed th e  truncation  m utants for 7G6 
im m unoreactivity by W estern  blot analysis. Because hum an 
and bovine cArr C term ini are nearly identical and distinct from  
the  C term ini o f o ther cone arrestins, w e suspected  tha t the 
ep itope  fo r mAb 7G6 may be located  there , particularly be­
cause th is reg ion  carries a num ber o f charged residues and is 
p red ic ted  to  be antigenic by exposure on  th e  surface of the 
m olecule (see Fig. 2 in  Ref. 28). H ow ever, C-terminal deletion 
m utants in  w hich  23 and 35 C-terminal residues w ere rem oved 
by site d irected  m utagenesis (A4 and A5 in  Fig. 5), w ere still 
im m unoreactive (Fig. 6 , bottom ). W e th en  deleted residues 
188-388 (A3 in  Fig. 5), 169-388 (A2), and 98-388 (A l) in  cone 
arrestin, and only deletion  m utan t A l was show n to be iinmu- 
nonegative w ith  7G6 (Fig. 6 , top). Inspection  o f th e  sequence 
alignm ent narrow ed  th e  antigenic determ inant fo r 7G6 in hu­
m an cArr to  a short reg ion  in  the N-domain. This reg ion  is 
nearly identical in  hum an and bovine cArr, bu t divergent in  
roden t and o th er vertebrate cone arrestin  sequences. W e con­
clude tha t th e  ep itope  recognized by mAb 7G6 is located in  
this divergent loop  exposed  to  th e  surface of cone arrestin.
D is c u s s io n
W e have show n tha t a widely used im m unocytochem ical cone 
m arker recognizes cone arrestin, a regulatory com ponen t o f 
the  cone cascade. Using deletion m utants o f hum an cone 
arrestin, w e have show n tha t th e  antigenic determ inant is 
located in  a divergent surface-exposed loop  in  th e  N-domain of 
cone arrestin, assum ing tha t cone  arrestin  has a three-dim en­
sional struc tu re  tha t is very similar to  rod  arrestin. The high 
sequence conservation b e tw een  rod and cone arrestins (Fig. 5) 
largely justifies this conclusion. The p roposed  antigenic deter­
m inant is nearly identical in  bovine and hum an cone arrestin, 
bu t is divergent in  o ther cone arrestin  sequences, consistent 
w ith  th e  p resence  of th e  7G6 ep itope  only in hum an, prim ate, 
and bovine retinas.
The function  of arrestins consists o f desensitizing a G-pro- 
te in -co u p led  recep to r (in pho to recep to rs, th e  rod  and cone 
pigm ents). Similar to  rod  arrestin  (for review , see Ref. 30), the 
function  o f cone arrestin  is p resum ed  to  consist o f in teracting  
w ith  phosphory lated  cone visual p igm ents and dow nregulating 
o r quenching th e  cone cascade, thus contribu ting  to  desensi­
tization and light adapta tion .51 R egeneration of th e  rod  and 
cone visual p igm ents is though t to  requ ire  phosphory lation  by 
a rhodopsin  kinase term ed  GRK I ^  o r by bo th  GRK1 and 
GRK7.???i
R ecom binant cone arrestins show  little affinity fo r phos­
phorylated  or nonphosphory lated  rhodopsin .55 56 In vitro 
w ork w ith  recom binant m ouse cone arrestin  suggests th a t it 
in teracts w ith  ch icken cone p igm ents in a light- and phospho ­
rylation-dependent m a n n e r .B a s e d  on crystal structure  data 
o f rod  arrestin, it is assum ed tha t the  re cep to r’s C-terminal tail
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F igure  5. Determination of the 7G6 epitope. Amino acid sequence alignment of rod (Arr) and cone arrestins (cArr). Black triangles, above and 
below the human and zebrafish sequences, respectively, indicate positions of introns in the gene sequences. Black arrows-, truncated areas in 
mutants of human cone arrestin (Al - A5). Shaded bars 1 to 4 : divergent areas. The three-dimensional structure of rod arrestin is indicated above 
the bovine rod arrestin sequence, large arrows, fi sheets: cylinders, a-helices.
containing th e  phosphorylation  sites acts as a sw itch to  induce action w as p ro p o sed  in solution on th e  basis o f small angle 
a conform ational change in arrestins tha t enables binding to  x-ray scattering experim en ts .38 Rod arrestin ’s binding to  the 
the  recep to r/ 8-37 A similar m odel for arrestin /recep to r inter- recep to r is sensitive to  alternative splicing and  missense muta-
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cArr A5 A4
F igure  6 . Analysis o f  deletion m utan ts by W estern blot analysis. The 
hum an recombinant Ilis-tagged X-arrestin and its deletion m utants Al 
to A 5 were run on  10% SDS-PAGF. gel and transferred to nitrocellulose 
membrane. Top: Ilis-tagged m utants Al to A3 were probed with mAb 
7G6 (1:150 dilution). Middle: same m utants probed with anti-IIis-tag 
antibody. Note that the Al mutant was expressed and immunopositive 
with anti-IIis-tag antibody, but negative with 7G6. Bottom: m utant A4 
and A5 probed with mAb 7G6.
tions. A bovine arrestin splice variant (p44) w ithou t the C- 
term inal p ep tid e  encoded  by the  last exon can b ind  to unphos- 
phorylated  rhodopsin .59 Arrestin m utant R175Q binds to 
activated phosphory lated  and unphosphory lated  rhodopsin, 
and Arr (R175B) binds to b leached  rhodopsin  from w hich  the 
C-terminal phosphorylation  sites have been  rem oved . 10 O ther 
residues (1)30, R175, 1)296, and 1)303 based on the bovine 
arrestin sequence) have been identified that enable binding to 
nonphosphory lated  rhodopsin .57 The m utant arrestins are p re ­
sum ably sw itched  into the active conform ation in the absence 
o f rhodopsin  phosphorylation. All these residues are well con­
served in cone arrestins (Fig. 5, asterisks), suggesting a similar 
functional role o f cone arrestin in quenching the cone cascade. 
The uniform  distribution of cone arrestin th roughout the cell 
indicates that it diffuses freely in the  cytoplasm . We cannot 
exclude that cone  arrestin may have additional functions un­
related to  quenching  the cone cascade.
Malfunctioning in recep to r phosphorylation  (in w hich 
there  is no quenching  of the cascade) has been  linked to 
cardiac disease in transgenic animal m odels11 and  to congenital 
stationary7 n ight blindness in hum ans. 12,15 Patients w ith  natu­
rally occurring  m utations in rod  arrestin have O guchi disease, 
a form of inherited  stationary' night b lindness. 11 In arrestin- 
knockout mice, pho to responses are prolonged, consistent 
w ith  the absence of quench ing . 15 In addition, it has been 
dem onstrated  that excessive light can cause rod  cell death  in 
p igm ented  rod  arrestin-knockout m ice .16” 1** In hum an, the 
cArr gene is located on the long arm of the X chrom osom e near 
the cen trom ere (Xcen-Xq22).~5 Because cone arrestin ’s p re ­
sum ed quenching  capacity' m ust be  vital for p ro p e r cone func­
tioning, its gene is considered  a candidate gene for cone dys­
trophies o r m acular degenerations. No defects in th e  cone 
arrestin gene have so far been  linked to hum an retinal dystro­
phies. In preliminary' experim ents, w e  screened  th ree patients 
w ith  X-linked cone disease for disease-causing m utations, bu t 
no m utation w as identified (results no t show n).
The m ovem ent o f arrestins and  transducin subunits in rods 
and cones is an interesting phenom enon  represen ting  a novel 
m echanism  of ligh t-dark  adaptation. In light, arrestins accu­
m ulate in the o u te r segm ents to  quench  th e  photo transduetion  
cascades. Rod transducin subunits, in contrast, m ove in the 
opposite  d irec tio n ' 119,50 to desensitize the cascade. The traffic 
from the  inner to the o u te r segm ents m ust pass th rough  a 
narrow  in terconnecting  cilium in bo th  rods and  cones. In 
Kif3A conditional knockout mice, arrestin and rhodopsin  trans­
port, bu t no t transducin transport, w as show n to be dependen t 
on kinesin II, a ubiquitous m olecular m oto r51 p resen t in the 
cilium. Unresolved questions include the m echanism s that trig­
ger the relocalization of these com ponents and exactly  w hich 
m otors and  m otor subunits are involved in translocation.
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